← Mechanisms of action
Staphylococcus aureus
ORGANISMStaphylococcus aureus
Drugs acting on this target (26)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| sodium deoxyribonucleate (Derinat) | Blocker | approved | Small molecule | Staphylococcus aureus blocker |
| bivalent rluks-pv / rat | Immunity, active | experimental | Vaccine | Staphylococcus aureus immunity, active |
| gsk2392019a | Immunity, active | experimental | Vaccine | Staphylococcus aureus immunity, active |
| ltb-sa7 | Immunity, active | experimental | Vaccine | Staphylococcus aureus immunity, active |
| recombinant staphylococcus aureus vaccine | Immunity, active | experimental | Vaccine | immunity, active - staphylococcus aureus |
| s. aureus type 5 & 8 capsular polysaccharide conjugate | Immunity, active | experimental | Vaccine | Staphylococcus aureus immunity, active |
| sa-5ag | Immunity, active | experimental | Vaccine | Staphylococcus aureus immunity, active |
| sa3ag | Immunity, active | experimental | Vaccine | Staphylococcus aureus immunity, active |
| sa4ag vaccine | Immunity, active | experimental | Vaccine | Staphylococcus aureus immunity, active |
| staph aureus types 5 and 8 conjugate vaccine | Immunity, active | experimental | Vaccine | Staphylococcus aureus immunity, active |
| staphylococcus aureus 4-antigen vaccine | Immunity, active | experimental | Vaccine | Staphylococcus aureus immunity, active |
| staphylococcus aureus toxoids | Immunity, active | experimental | Vaccine | Staphylococcus aureus immunity, active |
| staphylococcus aureus vaccine | Immunity, active | experimental | Vaccine | Staphylococcus aureus immunity, active |
| Staphylococcus aureus vaccine(Escherichia Coli) | Immunity, active | experimental | Vaccine | Staphylococcus aureus immunity, active |
| v710 | Immunity, active | experimental | Vaccine | Staphylococcus aureus immunity, active |
| buccalin | Immunity, passive | experimental | Vaccine | Staphylococcus aureus immunity, passive |
| dsta4637s | Immunity, passive | experimental | mAb | Staphylococcus aureus immunity, passive |
| fontolizumab | Immunity, passive | experimental | mAb | Staphylococcus aureus immunity, passive |
| kbsa301 | Immunity, passive | experimental | mAb | Staphylococcus aureus immunity, passive |
| medi4893 | Immunity, passive | experimental | mAb | Staphylococcus aureus immunity, passive |
| s. aureus immune globulin | Immunity, passive | experimental | Biological | Staphylococcus aureus immunity, passive |
| staphylococcus aureus immune globulin | Immunity, passive | experimental | Biological | Staphylococcus aureus immunity, passive |
| tefibazumab | Immunity, passive | experimental | mAb | Staphylococcus aureus immunity, passive |
| tosatoxumab (Salvecin) | Immunity, passive | experimental | mAb | Staphylococcus aureus immunity, passive |
| veronate | Immunity, passive | experimental | Biological | Staphylococcus aureus immunity, passive |
| p128 | Inhibitor | experimental | Recombinant protein | Staphylococcus aureus inhibitor |